Zinc is known for anti-inflammatory and antioxidant roles. In this meta-analysis, we aim to evaluate the impact of zinc supplementation on inflammatory markers, acute-phase reactants, and serum zinc level during inflammatory and infectious diseases. PubMed, Scopus, and Web of Science databases were screened systematically with the terms “zinc supplementation” AND “CRP” OR “IL-1β” OR “IL-2” OR “IL-6” OR “IL-10” OR “IL-12” OR “TNF-α” OR “TGF-β” OR “IFN-γ” OR “WBC (clinical trial)” OR “macrophage (clinical trial)” OR “lymphocyte (clinical trial)” OR “neutrophil (clinical trial)” OR “virus (clinical trial)” OR “antiviral (clinical trial)” for all databases. A total of 2,258 publications were screened, and 73 articles had suitable data for the meta-analysis. Serum zinc level was significantly higher in supplementation group compared with controls [P = 0.0006, mean difference: 11.35 (4.84, 17.87)] (n = 37). Zinc supplementation downregulates acute-phase reactants, especially serum C-reactive protein (CRP) in adults [P < 0.00001, mean difference: −0.75 (−0.98, −0.52)] (n = 22) and pregnant women [FEM P < 0.00001, mean difference: −1.77 (−2.53, −1.00)] (n = 3) but not in children [REM P = 0.10, mean difference: −0.85 (−1.86, 0.17)] (n = 3). In subgroups analysis of chronic inflammatory diseases, serum CRP [REM P < 0.00001, mean difference: −0.57 (−0.76, −0.38)] were significantly lower in zinc-supplemented patients compared with no intervention group. Zinc supplementation (mg/day) correlated with serum interferon-gamma (IFN-γ) level (P = 0.018, r = 1,000). In the nonsupplemented group, serum zinc correlated with serum interleukin-6 (IL-6) level (P = 0.041, r = −0.829) and serum tumor necrosis factor alpha (TNF-α) level (P = 0.063, r = 0.730). Zinc intake correlated with serum zinc (P = 0.0428, r = 0.5115) and TNF-α (P = 0.0043, r = −0.9461). This meta-analysis shows that zinc supplementation improves CRP levels in adults and pregnant women. It might have modulatory effects on cytokine secretions and blood cells in inflammatory and infectious diseases. For the first time, we investigated the effects of zinc supplementation on inflammatory cytokine.
Get full access to this article
View all access options for this article.
References
1.
AbbasinazariM, AlavianSM, BehnavaB, AsghariniaM, SalimiS, KeshvariM, MehrnoushL, KarimP. 2014. Effect of zinc supplementation on viral response in patients with chronic hepatitis C and Beta thalassemia major, a pilot study. J Clin Diagn Res, 8(12):HC16.
2.
AdrianiM, WirjatmadiB. 2014. The effect of adding zinc to vitamin A on IGF-1, bone age and linear growth in stunted children. J Trace Elem Med Biol, 28(4):431–435.
3.
Adu-AfarwuahS, LarteyA, OkronipaH, AshornP, ZeilaniM, BaldiviezLM, OaksBM, VostiS, DeweyKG. 2017. Impact of small-quantity lipid-based nutrient supplement on hemoglobin, iron status and biomarkers of inflammation in pregnant Ghanaian women. Matern Child Nutr, 13(2):e12262.
4.
AhmadI, Al-AhmareK. 2016. Effect of vitamin A and zinc on circulating profile of IL-2, IL-12, and IFNγ cytokines in pulmonary tuberculosis patients. Int J Nutr Pharmacol Neurol Dis, 6(2):63.
5.
AkdasS, TuranB, DurakA, AyralPA, YazihanN. 2020. The relationship between metabolic syndrome development and tissue trace elements status and inflammatory markers. Biol Trace Elem Res, 198(1):16–24.
6.
AkdasS, YazihanN. 2020. Cord blood zinc status effects on pregnancy outcomes and its relation with maternal serum zinc levels: a systematic review and meta-analysis. World J Pediatr, 16(4):366–376.
7.
AkdasS, YazihanN. 2020. Serum zinc level and dietary zinc intake status in non-alcoholic fatty liver disease: a meta-analysis and systematic review. Hepatol Forum, 2:59–67.
AydemirTB, ChangS-M, GuthrieGJ, MakiAB, RyuM-S, KarabiyikA, CousinsRJ. 2012. Zinc transporter ZIP14 functions in hepatic zinc, iron and glucose homeostasis during the innate immune response (endotoxemia). PLoS One, 7(10):e48679.
10.
BaoB, PrasadAS, BeckFW, FitzgeraldJT, SnellD, BaoGW, SinghT, CardozoLJ. 2010. Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr, 91(6):1634–1641.
11.
BaoB, PrasadAS, BeckFW, SnellD, SunejaA, SarkarFH, DoshiN, FitzgeraldJT, SwerdlowP. 2008. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Transl Res, 152(2):67–80.
12.
BarnettJB, DaoMC, HamerDH, KandelR, BrandeisG, WuD, DallalGE, JacquesPF, SchreiberR, KongE, MeydaniSN. 2016. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr, 103(3):942–951.
13.
BogdenJ, OleskeJ, LavenharM, MunvesE, KempF, BrueningKS, HoldingKJ, DennyTN, GuarinoMA, KriegerLM, et al.1988. Zinc and immunocompetence in elderly people: effects of zinc supplementation for 3 months. Am J Clin Nutr, 48(3):655–663.
14.
BorensteinM, HedgesLV, HigginsJP, RothsteinHR. 2009. Fixed-effect versus random-effects models. Introduction to meta-analysis. Vol 77, pp 85.
15.
BraunschweigCL, SowersM, KovacevichDS, HillGM, AugustDA. 1997. Parenteral zinc supplementation in adult humans during the acute phase response increases the febrile response. J Nutr, 127(1):70–74.
16.
BrignolaC, BelloliC, De SimoneG, EvangelistiA, ParenteR, ManciniR, IannoneP, MocheggianiE, FabrisN, MoriniMC, et al.1993. Zinc supplementation restores plasma concentrations of zinc and thymulin in patients with Crohn's disease. Aliment Pharmacol Ther, 7(3):275–280.
17.
CeylanMN, AkdasS, YazihanN. 2021. Is zinc an important trace element on bone turnover related complications: a meta-analysis and systematic review from serum level, dietary intake and supplementation aspects. Biol Trace Elem Res, 199(2):535–549.
18.
CostarelliL, GiacconiR, MalavoltaM, BassoA, PiacenzaF, DeMartiisM, GiannandreaE, RenieriC, BuscoF, GaleazziR, MocchegianiE. 2014. Effects of zinc-fortified drinking skim milk (as functional food) on cytokine release and thymic hormone activity in very old persons: a pilot study. Age, 36(3):9656.
19.
de MouraMSB, SoaresNRM, de Lima BarrosSÉ, de PinhoFA, SilvaTMC, BrázDC, VieiraEC, LimaMM, ParenteJML, do Nascimento MarreiroD, da SilvaAS, do Nascimento NogueiraN. 2020. Zinc gluconate supplementation impacts the clinical improvement in patients with ulcerative colitis. Biometals, 33(1):15–27.
20.
DerosaG, D'AngeloA, RomanoD, MaffioliP. 2016. A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients. Int J Mol Sci, 17(11):1802.
21.
DiasPCS, Sena-EvangelistaKCM, de Oliveira PaivaMSM, FerreiraDQC, UrurahyMAG, RezendeAA, AbdallaDSP, PedrosaLFC. 2014. The beneficial effects of rosuvastatin are independent of zinc supplementation in patients with atherosclerosis. J Trace Elem Med Biol, 28(2):194–199.
22.
DioufA, BadianeA, MangaNM, Idohou-DossouN, SowPS, WadeS. 2016. Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial. BMC Public Health, 16(1):1.
23.
DuchateauJ, DelepesseG, VrijensR, ColletH. 1981. Beneficial effects of oral zinc supplementation on the immune response of old people. Am J Med, 70(5):1001–1004.
24.
EbrahimiFA, ForoozanfardF, AghadavodE, BahmaniF, AsemiZ. 2018. The effects of magnesium and zinc co-supplementation on biomarkers of inflammation and oxidative stress, and gene expression related to inflammation in polycystic ovary syndrome: a randomized controlled clinical trial. Biol Trace Elem Res, 184(2):300–307.
25.
FariasMS, BudniP, RibeiroCM, ParisottoEB, SantosCEI, DiasJF, DalmarcoEM, FrödeTS, PedrosaRC, Wilhelm FilhoD. 2012. Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients. Gastroenterol Hepatol, 35(6):386–394.
26.
FosterM, PetoczP, SammanS. 2013. Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus. J Nutr Biochem, 24(9):1655–1661.
27.
FukudaS, KoyamaH, KondoK, FujiiH, HirayamaY, TabataT, OkamuraM, YamakawaT, OkadaS, HirataS, KiyamaH, KajimotoO, WatanabeY, InabaM, NishizawaY. 2015. Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial. PLoS One, 10(3):e0119578.
28.
GermolecDR, FrawleyRP, EvansE. 2010. Markers of inflammation. In: Immunotoxicity testing. Springer, pp. 53–73.
29.
GhaffariH, TavakoliA, MoradiA, TabarraeiA, Bokharaei-SalimF, ZahmatkeshanM, FarahmandM, JavanmardD, KianiSJ, EsghaeiM, Pirhajati-MahabadiV, MonavariSH, Ataei-PirkoohA. 2019. Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine. J Biomed Sci, 26(1):70.
30.
GloszCM, SchaffnerAA, ReavesSK, ManaryMJ, PapathakisPC. 2018. Effect of nutritional interventions on micronutrient status in pregnant Malawian women with moderate malnutrition: a randomized, controlled trial. Nutrients, 10(7):879.
31.
GreenJ, LewinS, WightmanF, LeeM, RavindranS, PatonN. 2005. A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis, 9(12):1378–1384.
32.
HigginsJ. 2011. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www.cochrane-handbook.org.
HimotoT, HosomiN, NakaiS, DeguchiA, KinekawaF, MatsukiM, YachidaM, MasakiT, KurokochiK, WatanabeS, SendaS, KuriyamaS. 2007. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol, 42(9):1078–1087.
35.
HodkinsonCF, KellyM, AlexanderHD, BradburyI, RobsonPJ, BonhamMP, O'ConnorJM, CoudrayC, StrainJJ, WallaceJMW. 2007. Effect of zinc supplementation on the immune status of healthy older individuals aged 55–70 years: the ZENITH Study. J Gerontol A Biol Sci Med Sci, 62(6):598–608.
HopkinsMH, FedirkoV, JonesDP, TerryPD, BostickRM. 2010. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial. Cancer Epidemiol Biomarkers Prev, 19(3):850–858.
38.
IsakovVA, BogdanovaAA, BessonovVV, SentsovaTB, TutelyanVA, LinY, KazlovaV, HongJ, VelliquetteRA. 2018. Effects of multivitamin, multimineral and phytonutrient supplementation on nutrient status and biomarkers of heart health risk in a Russian population: a randomized, double blind, placebo controlled study. Nutrients, 10(2):120.
39.
IsbaniahF, WiyonoWH, YunusF, SetiawatiA, TotzkeU, VerbruggenM. 2011. Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial. J Clin Pharm Ther, 36(5):568–576.
40.
IslamMR, AttiaJ, AliL, McEvoyM, SelimS, SibbrittD, AkhterA, AkterS, PeelR, FaruqueO, MonaT, LonaH, MiltonAH. 2016. Zinc supplementation for improving glucose handling in pre-diabetes: a double blind randomized placebo controlled pilot study. Diabetes Res Clin Pract, 115:39–46.
41.
JamilianM, ForoozanfardF, BahmaniF, TalaeeR, MonavariM, AsemiZ. 2016. Effects of zinc supplementation on endocrine outcomes in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biol Trace Elem Res, 170(2):271–278.
42.
KahmannL, UciechowskiP, WarmuthS, MalavoltaM, MocchegianiE, RinkL. 2006. Effect of improved zinc status on T helper cell activation and TH1/TH2 ratio in healthy elderly individuals. Biogerontology, 7(5–6):429–435.
43.
KaramaliM, HeidarzadehZ, SeifatiS-M, SamimiM, TabassiZ, TalaeeN, BahardoostH, AsemiZ. 2016. Zinc supplementation and the effects on pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes, 124(1):28–33.
44.
KawaguchiT, NagaoY, AbeK, ImazekiF, HondaK, YamasakiK, MiyanishiK, TaniguchiE, KakumaT, KatoJ, SeikeM, YokosukaO, OhiraH, SataM. 2015. Effects of branched-chain amino acids and zinc-enriched nutrients on prognosticators in HCV-infected patients: a multicenter randomized controlled trial. Mol Med Rep, 11(3):2159–2166.
45.
KelishadiR, HashemipourM, AdeliK, TavakoliN, Movahedian-AttarA, ShapouriJ, PoursafaP, RouzbahaniA. 2010. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord, 8(6):505–510.
46.
KhanMI, SiddiqueKU, AshfaqF, AliW, ReddyHD, MishraA. 2013. Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients. J Nat Sci Biol Med, 4(2):336.
47.
KhazdouzM, MazidiM, EhsaeiM-R, FernsG, KengneAP, NorouzyA-R. 2018. Impact of zinc supplementation on the clinical outcomes of patients with severe head trauma: a double-blind randomized clinical trial. J Diet Suppl, 15(1):1–10.
48.
KhorsandiH, NikpayamO, YousefiR, ParandooshM, HosseinzadehN, SaidpourA, GhorbaniA. 2019. Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial. Diabetol Metab Syndr, 11(1):101.
49.
KilicM, BaltaciAK, GunayM. 2004. Effect of zinc supplementation on hematological parameters in athletes. Biol Trace Elem Res, 100(1):31–38.
50.
KimJ, AhnJ. 2014. Effect of zinc supplementation on inflammatory markers and adipokines in young obese women. Biol Trace Elem Res, 157(2):101–106.
51.
KimKI, KimSR, SasaseN, AkimotoY, ShikataM, OhtaniA, HirookaT, TanakaK. 2008. Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C. Hepatol Int, 2(1):111–115.
52.
KoW-S, GuoC-H, HsuG-SW, ChiouY-L, YehM-S, YaunS-R. 2005. The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin. Clin Biochem, 38(7):614–620.
53.
KuloğluZ, KırbaşG, ErdenE, KansuA. 2011. Interferon-alpha-2a and zinc combination therapy in children with chronic hepatitis B infection. Biol Trace Elem Res, 143(3):1302–1309.
54.
LiuzziJP, LichtenLA, RiveraS, BlanchardRK, AydemirTB, KnutsonMD, GanzT, CousinsRJ. 2005. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A, 102(19):6843–6848.
55.
MarianiE, NeriS, CattiniL, MocchegianiE, MalavoltaM, DedoussisGV, KanoniS, RinkL, JajteJ, FacchiniA. 2008. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and −174 IL-6 polymorphic alleles. Exp Gerontol, 43(5):462–471.
56.
MatsumuraH, NireiK, NakamuraH, ArakawaY, HiguchiT, HayashiJ, YamagamiH, MatsuokaS, OgawaM, NakajimaN, TanakaN, MoriyamaM. 2012. Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C. J Clin Biochem Nutr, 51(3):178–184.
57.
MaywaldM, WangF, RinkL. 2018. Zinc supplementation plays a crucial role in T helper 9 differentiation in allogeneic immune reactions and non-activated T cells. J Trace Elem Med Biol, 50:482–488.
58.
MazzattiD, MalavoltaM, WhiteA, CostarelliL, GiacconiR, MutiE, CiprianoC, PowellJR, MocchegianiE. 2008. Effects of interleukin-6 − 174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageing. Exp Gerontol, 43(5):423–432.
59.
MeksawanK, SermsriU, ChanvorachoteP. 2014. Zinc supplementation improves anticancer activity of monocytes in type-2 diabetic patients with metabolic syndrome. Anticancer Res, 34(1):295–299.
60.
MelicharB, MalírF, TichýM. 1993. Urinary zinc excretion in patients with different disorders: the acute phase response in the kidney. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, 36(4–5):325–335.
61.
MesdaghiniaE, NaderiF, BahmaniF, ChamaniM, GhaderiA, AsemiZ. 2019. The effects of zinc supplementation on clinical response and metabolic profiles in pregnant women at risk for intrauterine growth restriction: a randomized, double-blind, placebo-controlled trial. J Matern Fetal Neonatal Med. 1–7.
62.
MikirovaNA, KesariS, IchimTE, RiordanNH. 2017. Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood. J Transl Med, 15(1):213.
63.
MurakamiY, KoyabuT, KawashimaA, KakibuchiN, KawakamiT, TakaguchiK, KitaK, OkitaM. 2007. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon α-2b and ribavirin. J Nutr Sci Vitaminol (Tokyo), 53(3):213–218.
64.
NagamineT, TakagiH, TakayamaH, KojimaA, KakizakiS, MoriM, NakajimaK. 2000. Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b. Biol Trace Elem Res, 75(1–3):53–63.
65.
PakasiTA, KaryadiE, SuratihNMD, SaleanM, DarmawidjajaN, BorH, van der VeldenK, DolmansWMV, van der MeerJWM. 2010. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutr J, 9(1):41.
66.
PourteymourFTF, AlipoorB, OstadrahimiA, MehrzadSM. 2011. Effect of zinc supplementation on inflammatory markers in women with polycystic ovary syndrome. Shiraz E Med J, 12(1):30–38.
67.
PrasadAS, BaoB, BeckFW, KucukO, SarkarFH. 2004. Antioxidant effect of zinc in humans. Free Radic Biol Med, 37(8):1182–1190.
68.
PrasadAS, BaoB, BeckFW, SarkarFH. 2011. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB. Nutrition, 27(7–8):816–823.
69.
PrasadAS, BeckFW, BaoB, FitzgeraldJT, SnellDC, SteinbergJD, CardozoLJ. 2007. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr, 85(3):837–844.
70.
PrasadAS, BeckFW, KaplanJ, ChandrasekarPH, OrtegaJ, FitzgeraldJT, SwerdlowP. 1999. Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol, 61(3):194–202.
71.
ProvincialiM, MontenovoA, StefanoGD, ColomboM, DaghettaL, CairatiM, VeroniC, CassinoR, Della TorreF, FabrisN. 1998. Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Ageing, 27(6):715–722.
72.
RahfiludinMZ, GinandjarP. 2013. The effect of zinc and vitamin C supplementation on hemoglobin and hematocrit levels and immune response in patients with Plasmodium vivax malaria. Southeast Asian J Trop Med Public Health, 44(5):733.
73.
RanjbarE, ShamsJ, Sabetkasaei MM-S, hiraziM, RashidkhaniB, MostafaviA, BornakE, NasrollahzadehJ. 2014. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci, 17(2):65–71.
74.
RashidiAA, SalehiM, PiroozmandA, SaghebMM. 2009. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients. J Ren Nutr, 19(6):475–478.
75.
ReinholdD, AnsorgeS, GrüngreiffK. 1997. Zinc regulates DNA synthesis and IL-2, IL-6, and IL-10 production of PWM-stimulated PBMC and normalizes the periphere cytokine concentration in chronic liver disease. J Trace Elem Exp Med, 10(1):19–27.
76.
RiccioniG, GammoneMA, CurrentiW, D'OrazioN. 2018. Effectiveness and safety of dietetic supplementation of a new nutraceutical on lipid profile and serum inflammation biomarkers in hypercholesterolemic patients. Molecules, 23(5):1168.
77.
RosenkranzE, HilgersR-D, UciechowskiP, PetersenA, PlümäkersB, RinkL. 2017. Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects. Eur J Nutr, 56(2):557–567.
78.
SangthawanD, PhungrassamiT, SinkitjarurnchaiW. 2015. Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy. Nutr Cancer, 67(3):449–456.
79.
Sena-EvangelistaKCM, PedrosaLFC, PaivaMSMO, DiasPCS, FerreiraDQC, CozzolinoSMF, FaulinTES, AbdallaDSP. 2015. The hypolipidemic and pleiotropic effects of rosuvastatin are not enhanced by its association with zinc and selenium supplementation in coronary artery disease patients: a double blind randomized controlled study. PLoS One, 10(3):e0119830.
80.
SinghA, FaillaML, DeusterPA. 1994. Exercise-induced changes in immune function: effects of zinc supplementation. J Appl Physiol, 76(6):2298–2303.
81.
SkalnyAV, RinkL, AjsuvakovaOP, AschnerM, GritsenkoVA, AlekseenkoSI, SvistunovAA, PetrakisD, SpandidosDA, AasethJ, TsatsakisA, TinkovAA. 2020. Zinc and respiratory tract infections: perspectives for COVID-19. Int J Mol Med, 46(1):17–26.
82.
SoaresNRM, de MouraMSB, de PinhoFA, SilvaTMC, de Lima BarrosSÉ, de Castro AmorimA, VieiraEC, NetoJMM, ParenteJML, e CruzMdSP, MarreiroDN, NogueiraNDN. 2018. Zinc supplementation reduces inflammation in ulcerative colitis patients by downregulating gene expression of Zn metalloproteins. PharmaNutrition, 6(3):119–124.
83.
SomeyaY, TanihataJ, SatoS, KawanoF, ShiratoK, SugiyamaM, KawashimaY, NomuraS, TachiyashikiK, ImaizumiK. 2009. Zinc-deficiency induced changes in the distribution of rat white blood cells. J Nutr Sci Vitaminol, 55(2):162–169.
84.
SugawaraK, TakahashiH, KashiwaguraT, YamadaK, YanagidaS, HommaM, DairikiK, SasakiH, KawagoshiA, SatakeM, ShioyaT. 2012. Effect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD. Respir Med, 106(11):1526–1534.
85.
SuliburskaJ, SkrypnikK, SzulińskaM, KupszJ, BogdańskiP. 2018. Effect of hypotensive therapy combined with modified diet or zinc supplementation on biochemical parameters and mineral status in hypertensive patients. J Trace Elem Med Biol, 47:140–148.
86.
SuzukiH, TakagiH, SoharaN, KandaD, KakizakiS, SatoK, MoriM. 2006. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial. World J Gastroenterol, 12(8):1265.
87.
TakagiH, NagamineT, AbeT, TakayamaH, SatoK, OtsukaT, KakizakiS, HashimotoY, MatsumotoT, KojimaA, TakezawaJ, SuzukiK, SatoS, MoriM. 2001. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepat, 8(5):367–371.
88.
Te VelthuisAJ, van den WormSH, SimsAC, BaricRS, SnijderEJ, van HemertMJ. 2010. Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog, 6(11):e1001176.
89.
UnverN, McAllisterF. 2018. IL-6 family cytokines: key inflammatory mediators as biomarkers and potential therapeutic targets. Cytokine Growth Factor Rev, 41:10–17.
90.
VinodkumarM, ErhardtJG, RajagopalanS. 2009. Impact of a multiple-micronutrient fortified salt on the nutritional status and memory of schoolchildren. Int J Vitam Nutr Res, 79(56):348–361.
91.
WangLS, LinHY, ChangCJ, FahnHJ, HuangMH, LinCFJ. 1998. Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. J Surg Oncol, 67(2):90–98.
92.
WeideM, ZhaomingD, BaoliangL, HuibiX. 1991. Study of immune function of cancer patients influenced by supplemental zinc or selenium-zinc combination. Biol Trace Elem Res, 28(1):11–19.
93.
WillershausenB, RossA, FörschM, WillershausenI, MohauptP, CallawayA. 2011. The influence of micronutrients on oral and general health. Eur J Med Res, 16(11):514.
